Delivery Order SPE2DB22D1202-SPE2DB25FVBU5
Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp received a delivery order valued at $1,513.12 from the Defense Logistics Agency (DLA) on August 7, 2025, for Trelegy Ellipta 200-62.5-25, a combination respiratory medication used in treating chronic obstructive pulmonary disease. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. This delivery order is performed at the company's corporate office location...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 29, 2025, for $9,101.14 to supply Trelegy Ellipta 100-62.5-25 60S, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed by September 2, 2025, at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $5,057.09 delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This firm fixed-price delivery order, with a completion date of April 22, 2025, represents a competitive award with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- AmerisourceBergen Drug Corp received a delivery order contract valued at $37,479.45 from the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. The contract was completed on August 22, 2025, with performance...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,608.41 by the Defense Logistics Agency on April 29, 2025, with an ultimate completion date of April 30, 2025. The award covers Trelegy Ellipta 200-62.5-25, a combination respiratory medication used for chronic obstructive pulmonary disease and asthma management. This is a firm fixed-price delivery order with no set-aside designation, issued...
- The Defense Logistics Agency awarded a $66,535.75 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of July 30, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination inhaler medication for chronic obstructive pulmonary disease treatment). This competitively awarded, non-set-aside contract carries a ceiling value of $13,468.45 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The work will be performed at AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,046.46 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (a combination respiratory medication), with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units) valued at $101,693.21. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Trelegy...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,554.00 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). Issued on June 9, 2025, with an ultimate completion date of June 10, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...